You could make the case that the lines that separate an artist from an entrepreneur are virtually nonexistent.
Just like startup founders or other business owners, artists are passion-driven individuals. They are making a product and seeking to sell it in... Read more »
Seismic, an enterprise software company with ambitious growth plans, has raised $100 million in a Series E financing and added Microsoft chairman John W. Thompson to its board of directors.
The venture investment, which the San Diego startup announced Tuesday, is... Read more »
San Antonio — San Antonio has a new “action plan” for bringing more life sciences businesses and professionals to the city, as well as for retaining those it already has.
Economic development groups and city officials have been developing a strategy... Read more »
A year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche, Jonathan Lim is back at it again. Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to... Read more »
When it comes to getting a drug into a cell, size matters. Small molecules can easily pass through the cellular membrane in a way that larger therapeutic proteins can’t, which makes it difficult to develop a biological drug that can reach... Read more »
On Monday, Xconomy began our annual look ahead at clinical trials that could define biotech and have profound healthcare effects in the coming year. Today we’re circling back with the rest of the list, which includes studies of drugs for nonalcoholic... Read more »
Seattle biotech company Kineta continues to expand its roster of drug development partners, announcing on Monday it has entered into a collaboration and licensing agreement with Pfizer to develop therapies that use the body’s disease-fighting capabilities to attack cancerous tumors.
Pfizer... Read more »
Sophiris Bio said Monday that 10 patients who were administered its experimental prostate cancer drug a second time didn’t see any additional benefit.
The news sent the San Diego, CA-based biotech’s stock plunging 40 percent.
Sophiris (NASDAQ: SPHS) already had... Read more »
Warehouses run entirely by robots may not be waiting on the horizon, but that—and much more—remains a goal for Somerville, MA-based RightHand Robotics.
“A typical item delivered to a customer is touched four to 11 times before it ships,” says the... Read more »
Two years after closing a $400 million fund for biotech investing, Versant Ventures is at it again, this time with $700 million in two new funds.
The first of the new funds, Versant Venture Capital VII, is a $600... Read more »
It turns out we might have been making lithium-ion batteries all wrong this whole time.
That’s at least what Cambridge, MA-based battery startup 24M says, now having developed what it sees as the “right” way.
The company, a spinoff of A123... Read more »
[Editor’s note: This is part of a series of posts sharing thoughts from technology leaders about 2018 trends and 2019 forecasts.]
Today’s artificial intelligence technologies have demonstrated they’re capable of handling specific tasks, such as identifying pictures of cats... Read more »
Omid Farokhzad has, as he says, “been around the block a few times” in biotech. The cancer nanomedicine researcher has cofounded a handful of companies that have tried to develop nanotech-based and other drugs for cancer and other diseases. But their... Read more »